Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
about
Systemic delivery of oncolytic viruses: hopes and hurdlesContact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryRole of CX3CR1 receptor in monocyte/macrophage driven neovascularizationRANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycansAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Perfluorocarbon nanoparticles for physiological and molecular imaging and therapyPerspectives and opportunities for nanomedicine in the management of atherosclerosis.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsionsPerfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.alphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.The shunt problem: control of functional shunting in normal and tumour vasculature.Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment.Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.Atherosclerosis: from biology to pharmacological treatment.Inflammatory angiogenesis in atherogenesis--a double-edged sword.Atherosclerotic plaque development and instability: a dual role for VEGF.Optical and multimodality molecular imaging: insights into atherosclerosis.The value of multi-slice-computed tomography coronary angiography for risk stratification.Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method.AKT as locus of cancer angiogenic robustness and fragility.Thymosin β4 sustained release from poly(lactide-co-glycolide) microspheres: synthesis and implications for treatment of myocardial ischemia.Update on oncolytic viral therapy - targeting angiogenesisRole of the vasa vasorum and vascular resident stem cells in atherosclerosis.IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization?Therapeutic potential of novel modulators of neovascularization.Computationally simple analysis of matched, outcome-based studies of ordinal disease states.Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitudinal study.CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice.Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.Multifunctional regulation of angiogenesis by high-density lipoproteins.Improved plaque neovascularization following 2-year atorvastatin therapy based on contrast-enhanced ultrasonography: A pilot study.
P2860
Q21284969-36BACEC8-C770-4E99-9F05-040B5121B15CQ26795703-4AB2AE82-DF11-4F9C-B4B5-8C19BACE180AQ27313463-D4EDE939-37F8-4D88-B543-B8C5DD699D74Q28567974-114542C9-0C9D-4B8D-9C0A-EC39232A848DQ30399006-04F3C027-C9B8-4695-8655-71F699DF57E1Q30426880-52BD4738-D67F-48A8-B59B-85E93905817FQ30455490-1607FC89-477A-4AB2-959B-6DBF3603D70EQ30469815-0E172EEE-EF3D-4E59-BD91-5744A4EFF8F8Q30471456-A4347A04-833A-45DA-A40D-83717F5ED058Q30474759-6779B39A-BFA4-4A22-85F8-0DFF78016344Q30486235-17E03243-CBF0-4BD5-8C70-5E7659F32453Q30542073-DAC0F4DD-42AD-4F37-BB3B-AC9AF7660B26Q33424301-1476A810-8C33-44D3-B98F-9E8C419C14B9Q34785222-8CB36796-F127-415A-89B3-B012F8DC8D0AQ35029814-1E4D1893-92F0-4D4B-BC37-6EE796DEFD58Q35152154-ECAF5DDB-1431-496B-BB33-B5D29590DF85Q35650874-AF73A412-9C6E-47BB-9449-B315EA3042FDQ36313684-9C2C61D4-76BF-4FD9-A5B3-AC985F34601BQ37209762-34630AB4-5885-4F84-8103-C8E5C0C01AB1Q37352918-7848B2FF-C9E8-4062-BC93-A594BC7D467FQ37440343-D5F6A9BA-6704-4C69-AF32-C15DEB0B0962Q37599612-52F84850-D1C1-4827-BAD2-0EBC491439F3Q37641072-2C5567B2-2A3C-4DC2-8619-9BF04A66AA67Q37668312-C4394D3E-B241-4CAD-9C59-70FE6022CC1EQ37720649-6CDC4678-AF38-410D-9BB1-DF74886087E8Q38010111-49617AC3-1B75-4195-9CB5-B80ABFE8D655Q38050840-F27D233C-6BF8-4B05-8A06-66AC54127175Q38128561-270B402D-EBB5-4651-A035-CEE33CE1D9B4Q38203884-901F2FBE-CECB-46DD-9FBB-343B129ACEEAQ39496836-D76B2BB5-04F6-4981-A8A6-9FC5AFD27A65Q39707225-8EC4B9AB-85D5-40D4-8257-802C46382EA3Q40076736-65AD8A3B-947E-4CD3-A380-7C0B1136E62EQ41031018-FC1458BF-A3EA-413A-95D1-123E3D101501Q45739358-7EB4EF6E-AD72-4490-BBE8-A1D2CB26D3D7Q48684077-C7044607-81B8-46F0-BA27-6A1A5BD18B83Q49851002-17F58E25-9E31-45BC-B6FF-C39308D4B9CEQ52886988-9AFA498F-0E8C-4656-9ABE-442D096D8B8DQ54310185-F9EDE96A-2E4E-4383-9E5B-CAB0EBA81FF5Q54402657-CA856A95-2109-4941-B9BA-757995DA6C20Q54960992-5470C8F3-BF76-4ED9-9E64-E56E8C60721F
P2860
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antiangiogenic therapy for nor ...... tegy for plaque stabilization.
@en
type
label
Antiangiogenic therapy for nor ...... tegy for plaque stabilization.
@en
prefLabel
Antiangiogenic therapy for nor ...... tegy for plaque stabilization.
@en
P2093
P2860
P356
P1476
Antiangiogenic therapy for nor ...... tegy for plaque stabilization.
@en
P2093
Aloke V Finn
Frank D Kolodgie
Herman K Gold
Rakesh K Jain
Renu Virmani
P2860
P304
P356
10.1038/NCPCARDIO0979
P577
2007-09-01T00:00:00Z